| Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells E Zavaczki, V Jeney, A Agarwal, A Zarjou, M Oros, M Katko, Z Varga, ... Kidney international 80 (7), 731-739, 2011 | 122 | 2011 |
| New formulations of levothyroxine in the treatment of hypothyroidism: trick or treat? EV Nagy, P Perros, E Papini, M Katko, L Hegedüs Thyroid 31 (2), 193-201, 2021 | 51 | 2021 |
| Simplifying complex insulin regimens while preserving good glycemic control in type 2 diabetes Z Taybani, B Bótyik, M Katkó, A Gyimesi, T Várkonyi Diabetes Therapy 10, 1869-1878, 2019 | 47 | 2019 |
| Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects H Lőrincz, M Katkó, M Harangi, S Somodi, K Gaál, P Fülöp, G Paragh, ... Clinical endocrinology 81 (3), 370-377, 2014 | 45 | 2014 |
| Effects of tocopherols and 2, 2′-carboxyethyl hydroxychromans on phorbol-ester-stimulated neutrophils Z Varga, E Kosaras, E Komodi, M Katko, I Karpati, J Balla, G Paragh, ... The Journal of Nutritional Biochemistry 19 (5), 320-327, 2008 | 38 | 2008 |
| Relationship between serum nickel and homocysteine concentration in hemodialysis patients M Katko, I Kiss, I Karpati, A Kadar, J Matyus, E Csongradi, J Posta, ... Biological trace element research 124, 195-205, 2008 | 32 | 2008 |
| Thyroglobulin level at week 16 of pregnancy is superior to urinary iodine concentration in revealing preconceptual and first trimester iodine supply M Katko, AA Gazso, I Hircsu, HP Bhattoa, Z Molnar, B Kovacs, D Andrasi, ... Maternal & Child Nutrition 14 (1), e12470, 2018 | 25 | 2018 |
| Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications N Zsíros, P Koncsos, H Lőrincz, I Seres, M Katkó, A Szentpéteri, VE Varga, ... Clinical biochemistry 49 (12), 862-867, 2016 | 17 | 2016 |
| Cell density-dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts E Galgoczi, F Jeney, A Gazdag, A Erdei, M Katko, DM Nagy, B Ujhelyi, ... J Endocrinol 229 (2), 187-96, 2016 | 17 | 2016 |
| Cerebrotendinous xanthomatosis with the c. 379 C> T (p. R127 W) mutation in the CYP27A1 gene associated with premature age-associated limbic tauopathy. I Kapás, M Katkó, M Harangi, G Paragh, I Balogh, Z Koczi, ... Neuropathology & Applied Neurobiology 40 (3), 2014 | 16 | 2014 |
| Lower educational status interferes with maternal iodine intake during both pregnancy and lactation L Samson, I Hircsu, M Katko, M Bodor, A Gazdag, AA Gazso, B Kovacs, ... Endocrine Connections 10 (7), 742-749, 2021 | 12 | 2021 |
| Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia A Szentpéteri, N Zsíros, VE Varga, H Lőrincz, M Katkó, I Seres, P Fülöp, ... Vasa 46 (5), 370-376, 2017 | 10 | 2017 |
| Different effects of cigarette smoke, heated tobacco product and e-cigarette vapour on orbital fibroblasts in graves’ orbitopathy; A study by real time cell electronic sensing JK Aranyosi, E Galgoczi, A Erdei, M Katko, M Fodor, Z Ujhelyi, I Bacskay, ... Molecules 27 (9), 3001, 2022 | 8 | 2022 |
| Characteristics of hyaluronan synthesis inhibition by 4-methylumbelliferone in orbital fibroblasts E Galgoczi, F Jeney, M Katko, A Erdei, A Gazdag, L Sira, M Bodor, E Berta, ... Investigative Ophthalmology & Visual Science 61 (2), 27-27, 2020 | 7 | 2020 |
| Plasminogen activator inhibitor type 1: a possible novel biomarker of late pituitary dysfunction after mild traumatic brain injury I Frendl, M Katko, E Galgoczi, J Boda, N Zsiros, Z Nemeti, Z Bereczky, ... Journal of Neurotrauma 34 (23), 3238-3244, 2017 | 6 | 2017 |
| Homocysteine metabolism in peripheral blood mononuclear cells: evidence for cystathionine beta-synthase activity in resting state M Katko, E Zavaczki, V Jeney, G Paragh, J Balla, Z Varga Amino Acids 43, 317-326, 2012 | 6 | 2012 |
| One‐year safety and efficacy results of insulin treatment simplification with IDegLira in type 2 diabetes ZJ Taybani, B Bótyik, A Gyimesi, M Katkó, T Várkonyi Endocrinology, Diabetes & Metabolism 6 (1), e390, 2023 | 4 | 2023 |
| The 4G/5G polymorphism of plasminogen activator inhibitor type 1 is a predictor of moderate-to-severe thyroid eye disease M Katko, E Galgoczi, A Erdei, A Gazdag, E Berta, M Bodor, I Seres, ... Journal of Inflammation Research, 1883-1890, 2021 | 2 | 2021 |
| Komplex inzulinkezelési rezsimek deeszkalációja a jó glikémiás kontroll megőrzésével 2-es típusú diabetes mellitusban ZJ Taybani, B Bótyik, M Katkó, A Gyimesi, P Kempler, T Várkonyi Diabetologia Hungarica 28 (1), 33-42, 2020 | 2 | 2020 |
| De-escalation of complex insulin regimens in well controlled patients with type 2 diabetes mellitus in everyday clinical practice Z Taybani, B Botyik, M Katko, A Gyimesi, T Varkonyi, P Kempler DIABETES STOFFWECHSEL UND HERZ 28 (6), 354-359, 2019 | 2 | 2019 |
